These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18192904)

  • 1. Allogeneic hematopoietic transplantation and leukemia: a second chance for T cells?
    Kuppen PJ
    Transplantation; 2008 Jan; 85(1):7-8. PubMed ID: 18192904
    [No Abstract]   [Full Text] [Related]  

  • 2. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of graft-versus-host disease by naturally occurring regulatory T cells.
    Zeng D; Lan F; Hoffmann P; Strober S
    Transplantation; 2004 Jan; 77(1 Suppl):S9-S11. PubMed ID: 14726761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft-versus-leukemia activity after T-cell depletion using counterflow centrifugation.
    de Witte T; Preijers F; Schattenberg A
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():103-5. PubMed ID: 2202463
    [No Abstract]   [Full Text] [Related]  

  • 7. T cell depletion in allogenic bone marrow transplantation. Progress and problems.
    Marmont AM
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():229-32. PubMed ID: 2653509
    [No Abstract]   [Full Text] [Related]  

  • 8. [Transplantation of hematopoietic stem cells].
    Hertenstein B; Novotny J; Ebell W; Ganser A
    Internist (Berl); 1996 Mar; 37(3):295-303. PubMed ID: 8919947
    [No Abstract]   [Full Text] [Related]  

  • 9. Mixed chimerism after allogeneic marrow transplantation.
    Frassoni F; Corvo R; Strada P; Sessarego M; Piaggio G; Figari O; Scarpati D; Bacigalupo A; Vitale V; Miceli S
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():241-3. PubMed ID: 2653512
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute graft versus host disease: pathophysiology, risk factors, and prevention strategies.
    Ferrara JL; Yanik G
    Clin Adv Hematol Oncol; 2005 May; 3(5):415-9, 428. PubMed ID: 16167015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic stem cells: good to the bone?
    Eisenstein M
    Lab Anim (NY); 2004 May; 33(5):10. PubMed ID: 15141230
    [No Abstract]   [Full Text] [Related]  

  • 12. Taming transplantation with T cells.
    Sakaguchi S
    Nat Med; 2003 Sep; 9(9):1117-8. PubMed ID: 12949524
    [No Abstract]   [Full Text] [Related]  

  • 13. [Umbilical cord blood for replacement of bone marrow for allogeneic transplantation of hematopoietic stem cells. Stichting Eurocord Nederland].
    Falkenburg JH; Lim FT
    Ned Tijdschr Geneeskd; 1995 Jul; 139(26):1319-22. PubMed ID: 7617048
    [No Abstract]   [Full Text] [Related]  

  • 14. [Graft-versus-leukemia reactions].
    Ju X; Wang J
    Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):443-5. PubMed ID: 11721426
    [No Abstract]   [Full Text] [Related]  

  • 15. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
    Liu YP; Li Z; Nador RG; Strober S
    Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protecting the host naturally.
    Sykes M; Spitzer TR
    Nat Med; 2005 Nov; 11(11):1164-5. PubMed ID: 16270073
    [No Abstract]   [Full Text] [Related]  

  • 18. [Towards the use of intravenous apoptotic leukocyte infusion as a cell-based therapy approach?].
    Saas P; Bonnefoy F; Kleinclauss F; Sun Y; Tiberghien P; Gaugler B; Perruche S
    Transfus Clin Biol; 2008 Jun; 15(3):98-108. PubMed ID: 18524660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Winning the battle of graft versus host.
    Martin PJ
    Nat Med; 2000 Jan; 6(1):18-9. PubMed ID: 10613813
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current status and issues in hematopoietic stem cell transplantation].
    Harada M
    Fukuoka Igaku Zasshi; 2007 Feb; 98(2):35-47. PubMed ID: 17396570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.